Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Aggressive Regimens Reduce Risk of Recurrence After Successful Treatment of MDR-TB.
Ahmad Khan F, Gelmanova IY, Franke MF, Atwood S, Zemlyanaya NA, Unakova IA, Andreev YG, Berezina VI, Pavlova VE, Shin SS, Yedilbayev AB, Becerra MC, Keshavjee S. Ahmad Khan F, et al. Among authors: gelmanova iy. Clin Infect Dis. 2016 Jul 15;63(2):214-20. doi: 10.1093/cid/ciw276. Epub 2016 May 8. Clin Infect Dis. 2016. PMID: 27161772
Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death.
Velásquez GE, Becerra MC, Gelmanova IY, Pasechnikov AD, Yedilbayev A, Shin SS, Andreev YG, Yanova G, Atwood SS, Mitnick CD, Franke MF, Rich ML, Keshavjee S. Velásquez GE, et al. Among authors: gelmanova iy. Clin Infect Dis. 2014 Jul 1;59(1):9-15. doi: 10.1093/cid/ciu209. Epub 2014 Apr 11. Clin Infect Dis. 2014. PMID: 24729493 Free PMC article.
Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.
Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Nikiforov M, Yedilbayev A, Mukherjee JS, Furin JJ, Barry DJ, Farmer PE, Rich ML, Keshavjee S. Shin SS, et al. Among authors: gelmanova iy. Int J Tuberc Lung Dis. 2006 Apr;10(4):402-8. Int J Tuberc Lung Dis. 2006. PMID: 16602404
Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia.
Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Yedilbayev A, Rich ML, Mukherjee JS, Furin JJ, Atwood S, Farmer PE, Keshavjee S. Shin SS, et al. Among authors: gelmanova iy. Int J Tuberc Lung Dis. 2007 Dec;11(12):1314-20. Int J Tuberc Lung Dis. 2007. PMID: 18034952
Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment.
Shin SS, Keshavjee S, Gelmanova IY, Atwood S, Franke MF, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Barnashov A, Tonkel TP, Cohen T. Shin SS, et al. Among authors: gelmanova iy. Am J Respir Crit Care Med. 2010 Aug 1;182(3):426-32. doi: 10.1164/rccm.200911-1768OC. Epub 2010 Apr 22. Am J Respir Crit Care Med. 2010. PMID: 20413630 Free PMC article.
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method.
Mitnick CD, White RA, Lu C, Rodriguez CA, Bayona J, Becerra MC, Burgos M, Centis R, Cohen T, Cox H, D'Ambrosio L, Danilovitz M, Falzon D, Gelmanova IY, Gler MT, Grinsdale JA, Holtz TH, Keshavjee S, Leimane V, Menzies D, Migliori GB, Milstein MB, Mishustin SP, Pagano M, Quelapio MI, Shean K, Shin SS, Tolman AW, van der Walt ML, Van Deun A, Viiklepp P; Collaborative Group for Analysis of Bacteriology Data in MDR-TB Treatment. Mitnick CD, et al. Among authors: gelmanova iy. Eur Respir J. 2016 Oct;48(4):1160-1170. doi: 10.1183/13993003.00462-2016. Epub 2016 Sep 1. Eur Respir J. 2016. PMID: 27587552 Free PMC article.
20 results